Nahdi Medical Company
4164
Rank in Stocks
#4862
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Share Price
$23.42
Market Cap
$3.05B
Change (1 day)
-0.45%
Change (1 year)
-27.09%
Country
SA
Trade Nahdi Medical Company (4164)
Category
Healthcare
P/E ratio for Nahdi Medical Company (4164)
P/E ratio as of October 2026 TTM: 14.29
According to Nahdi Medical Company latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.29. At the end of 2023 the company had a P/E ratio of 19.95.
P/E ratio history for Nahdi Medical Company from 2017 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 14.29 | -23.29% |
| 2024 | 18.63 | -6.64% |
| 2023 | 19.95 | -20.59% |
| 2022 | 25.13 | 4.70% |
| 2021 | 24.00 | 4.50% |
| 2020 | 22.97 | -18.50% |
| 2019 | 28.18 | -11.76% |
| 2018 | 31.93 | 18.11% |
| 2017 | 27.04 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 24.47 | 71.26% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 223.52 | 1,464.12% |
US
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.